Home > Insider Trading > Filing (0001225208-15-019424)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527599	Mirna Therapeutics Inc.	MIRN	Pharmaceutical Preparations (2834)	261824804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
78003	Pfizer Inc	235 East 42Nd Street New York NY 10017		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-10-05	1,539,224	$0.00	1,539,224	No	4	C	Direct
Common Stock	Acquisiton	2015-10-06	714,285	$7.00	2,253,509	No	4	P	Direct
Common Stock	Acquisiton	2015-10-06	235,855	$7.00	2,489,364	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Convertible Preferred Stock	Disposition	2015-10-05	1,047,806	$0.00	1,047,806	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2015-10-05	491,418	$0.00	491,418	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Each share of the issuer's Series C Convertible and Series D Convertible Preferred Stock converted into Common Stock of the issuer on a 1-to-1 basis immediately prior to the closing of the issuer's initial public offering, and has no expiration date.
The reporting person received 235,855 shares of Common Stock as a payment-in-kind dividend in connection with the conversion of the reporting person's Series C Convertible and Series D Convertible Preferred Stock into shares of Common Stock.